BD Oncology

How investing in automation can lead to short-term horizon return on investment (ROI)

The increasing demands on oncology services continue to stretch healthcare budgets, with the number of new cancer patients in Europe each year at 3.7 million1 and the total annual cost of cancer in the region at €199 billion2.

Cancer care currently consumes around 5% of all healthcare costs globally, with the growth in spending on cancer outstripping the growth in total health expenditure.3,4 This is not sustainable: budgets cannot keep rising indefinitely to meet these increasing needs.

One solution to help reduce oncology costs is through the implementation of automated* workflows. They can transform the oncology treatment pathway within hospitals, allowing organizations to increase efficiency, maximise resources, and ultimately reduce costs.

The initial investment required to implement new technologies can be a daunting prospect, especially as healthcare organisations are often already financially stretched. Therefore, having evidence demonstrating short-term horizon return on investment from the adoption of automated* workflows is important for key decision makers.

We will look at how automated* workflows within the oncology prescribing, compounding and administration processes can help:


Reduce medication errors


Reduce medication waste


Streamline the workflow from prescription to administration to increase capacity and free up staff time for other value-added tasks

Sign up today!

Access additional and exclusive content specific to your role - to support and inspire you through the challenges you face each day